337 related articles for article (PubMed ID: 22437759)
21. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
[TBL] [Abstract][Full Text] [Related]
22. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
[TBL] [Abstract][Full Text] [Related]
23. Substrates, inhibitors, and probes of mammalian transglutaminase 2.
Zhuang R; Khosla C
Anal Biochem; 2020 Feb; 591():113560. PubMed ID: 31874171
[TBL] [Abstract][Full Text] [Related]
24. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
[TBL] [Abstract][Full Text] [Related]
26. Activation of extracellular transglutaminase 2 by thioredoxin.
Jin X; Stamnaes J; Klöck C; DiRaimondo TR; Sollid LM; Khosla C
J Biol Chem; 2011 Oct; 286(43):37866-73. PubMed ID: 21908620
[TBL] [Abstract][Full Text] [Related]
27. Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
Klöck C; Jin X; Choi K; Khosla C; Madrid PB; Spencer A; Raimundo BC; Boardman P; Lanza G; Griffin JH
Bioorg Med Chem Lett; 2011 May; 21(9):2692-6. PubMed ID: 21215619
[TBL] [Abstract][Full Text] [Related]
28. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
[TBL] [Abstract][Full Text] [Related]
29. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
30. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.
Hodrea J; Demény MA; Majai G; Sarang Z; Korponay-Szabó IR; Fésüs L
Immunol Lett; 2010 May; 130(1-2):74-81. PubMed ID: 20005901
[TBL] [Abstract][Full Text] [Related]
31. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
32. Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.
Paolella G; Caputo I; Marabotti A; Lepretti M; Salzano AM; Scaloni A; Vitale M; Zambrano N; Sblattero D; Esposito C
PLoS One; 2013; 8(12):e84403. PubMed ID: 24391952
[TBL] [Abstract][Full Text] [Related]
33. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.
Di Simone N; De Spirito M; Di Nicuolo F; Tersigni C; Castellani R; Silano M; Maulucci G; Papi M; Marana R; Scambia G; Gasbarrini A
Biol Reprod; 2013 Oct; 89(4):88. PubMed ID: 23966323
[TBL] [Abstract][Full Text] [Related]
34. A molecular warhead and its target: tissue transglutaminase and Celiac Sprue.
Schuppan D; Dieterich W
Chem Biol; 2003 Mar; 10(3):199-201. PubMed ID: 12670530
[TBL] [Abstract][Full Text] [Related]
35. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
36. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
[TBL] [Abstract][Full Text] [Related]
37. Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
Plugis NM; Palanski BA; Weng CH; Albertelli M; Khosla C
J Biol Chem; 2017 Feb; 292(5):2000-2008. PubMed ID: 28003361
[TBL] [Abstract][Full Text] [Related]
38. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
[TBL] [Abstract][Full Text] [Related]
39. Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
Lindstad CB; du Pré MF; Stamnaes J; Sollid LM
PLoS One; 2022; 17(4):e0266543. PubMed ID: 35385534
[TBL] [Abstract][Full Text] [Related]
40. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]